ArticleComputational and structural biotechnology journal2022

Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing.

Max Luedemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.